睿智医药(300149)2月10日股东户数3.7万户，较上期减少1%

Core Insights - The company, Ruizhi Pharmaceutical, reported a decrease in the number of shareholders to 37,038 as of February 10, 2026, down by 376, or 1.0% from January 30, 2026 [1][2] - The average number of shares held per shareholder increased slightly from 13,300 to 13,400, with an average market value of 151,700 yuan per shareholder [1][2] - Compared to the industry average, Ruizhi Pharmaceutical's shareholder count is lower, with the medical services sector averaging 45,900 shareholders and an average market value of 351,100 yuan [1][2] Stock Performance - From January 30 to February 10, 2026, the stock price of Ruizhi Pharmaceutical increased by 8.05%, despite a reduction in shareholder count [1][2] - Over the preceding periods, the stock experienced fluctuations, including a decline of 3.33% from January 20 to January 30, 2026, and a notable increase of 14.54% from January 10 to January 20, 2026 [2] Capital Flow - During the period from January 30 to February 10, 2026, the company experienced a net outflow of 10.08 million yuan from institutional investors, while retail investors contributed a net inflow of 2.50 million yuan [4]